Zhansheng Zhu

Dr. Zhansheng Zhu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2012 in Cancer Research
Verified
Journal Article
Open access
PDF file
ZZZhansheng Zhu
Zhansheng Zhu
XGXueren Gao
Xueren Gao
YHYan He
Yan He
HZHua Zhao
Hua Zhao
QYQiang Yu
Qiang Yu
YGYuzhen Gao
Yuzhen Gao
The Prolyl hydroxylase 1 (EGLN2) is known to affect tumorigenesis by regulating the degradation of hypoxia-inducible factor. Polymorphisms in EGLN2 may facilitate cancer cell survival under hypoxic conditions and directly associate with cancer susceptibility. Here, we examined the contribution of a 4-bp insertion/deletion polymorphism (rs10680577) within the distal promoter of EGLN2 to the risk of hepatocelluar carcinoma (HCC) in Chinese populations. The contribution of rs10680577 to HCC risk was investigated in 623 HCC cases and 1,242 controls and replicated in an independent case–control study consisting of 444 HCC cases and 450 controls. Logistic regression analysis showed that the deletion allele of rs10680577 was significantly associated with increased risk for HCC occurrence in both case–control studies [OR = 1.40; 95% confidence interval (CI) = 1.18–1.66, P < 0.0001; OR = 1.49; 95% CI = 1.18–1.88, P = 0.0007]. Such positive association was more pronounced in current smokers (OR = 3.49, 95% CI = 2.24–5.45) than nonsmokers (OR = 1.24, 95% CI = 1.03–1.50; heterogeneity P = 0.0002). Genotype–phenotype correlation studies showed that the deletion allele was significantly correlated with higher expression of both EGLN2 and RERT-lncRNA [a long noncoding RNA whose sequence overlaps with Ras-related GTP-binding protein 4b (RAB4B) and EGLN2)] in vivo and in vitro. Furthermore, RERT-lncRNA expression was also significantly correlated with EGLN2 expression in vivo, consistent with in vitro gain-of-function study that showed overexpressing RERT-lncRNA upregulated EGLN2. Finally, in silico prediction suggested that the insertion allele could disrupt the structure of RERT-lncRNA. Taken together, our findings provided strong evidence for the hypothesis that rs10680577 contributes to hepatocarcinogenesis, possibly by affecting RERT-lncRNA structure and subsequently EGLN2 expression, making it a promising biomarker for early diagnosis of HCC. Cancer Res; 72(23); 6163–72. ©2012 AACR.

21 December 2015 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
ZZZhansheng Zhu
Zhansheng Zhu
JYJing Yan
Jing Yan
CGChunsong Geng
Chunsong Geng
DWDagang Wang
Dagang Wang
CLChaoyang Li
Chaoyang Li
ZZZhansheng Zhu
Zhansheng Zhu

1 October 2015 in Scientific Reports
Verified
Journal Article
Open access
XGXue-Ren Gao
Xue-Ren Gao
HWHui-Ping Wang
Hui-Ping Wang
SZShu-Long Zhang
Shu-Long Zhang
MWMing-Xi Wang
Ming-Xi Wang
ZZZhansheng Zhu
Zhansheng Zhu
MiR-124 functions as a tumor suppressor and plays an important role in tumorigenesis. A common polymorphism (rs531564, C>G) in the pri-miR-124 has been recently studied in connection with cancer risk. The aim of the present study was to investigate the association between pri-miR-124 rs531564 polymorphism and the risk and clinicopathological characteristics of colorectal cancer (CRC). Two case-control studies involving 900 CRC patients and 1110 cancer-free controls showed that pri-miR-124 rs531564 polymorphism was significantly associated with the decreased risk of CRC in Xuzhou population [GG vs. CC: OR = 0.25, 95%CI = 0.09–0.67, P = 0.003; (CG+GG) vs. CC: OR = 0.73, 95%CI = 0.56–0.94, P = 0.01; GG vs. (CC+CG): OR = 0.27, 95%CI = 0.10–0.70, P = 0.004; G vs. C: OR = 0.70, 95%CI = 0.56–0.89, P = 0.003], Bengbu population [GG vs. CC: OR = 0.20, 95%CI = 0.04–0.90, P = 0.02; GG vs. (CC+CG): OR = 0.21, 95%CI = 0.05–0.95, P = 0.03; G vs. C: OR = 0.72, 95%CI = 0.54–0.98, P = 0.03] and pooled population [GG vs. CC: OR = 0.26, 95%CI = 0.11–0.59, P<0.001; (CG+GG) vs. CC: OR = 0.76, 95%CI = 0.62–0.93, P = 0.008; GG vs. (CC+CG): OR = 0.27, 95%CI = 0.12–0.62, P < 0.001; G vs. C: OR = 0.71, 95%CI = 0.59–0.85, P<0.001]. Additionally, pri-miR-124 rs531564 polymorphism was significantly associated with the decreased risk of poor differentiation and lymph node metastasis of CRC. Our results suggest that pri-miR-124 rs531564 polymorphism may be a genetic modifier for developing CRC. However, further studies are needed to validate our findings.

12 August 2014 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
XGXueren Gao
Xueren Gao
SZShulong Zhang
Shulong Zhang
ZZZhansheng Zhu
Zhansheng Zhu

28 May 2024 in Aging
Verified
Journal Article
Open access
PDF file
ZZZhansheng Zhu
Zhansheng Zhu
SLShanwen Liang
Shanwen Liang
HYHong Yu
Hong Yu
YQYangzhi Qi
Yangzhi Qi
QSQIAN SUN
QIAN SUN
QCQianxue Chen
Qianxue Chen
Glioblastoma multiforme (GBM) is the most prevalent and lethal primary intracranial neoplasm in the adult population, with treatments of limited efficacy. Recently, bufotalin has been shown to have anti-cancer activity in a variety of cancers. This investigation aims to investigate the effect of bufotalin on GBM and elucidate its potential underlying mechanism. Our results show that bufotalin not only inhibits the proliferation and epithelial-mesenchymal transition (EMT) but also triggers apoptosis in GBM cells. The result of RNA-seq indicated that bufotalin could induce mitochondrial dysfunction. Moreover, our observations indicate that bufotalin induces an excessive accumulation of intracellular reactive oxygen species (ROS) in GBM cells, leading to mitochondrial dysfunction and the dephosphorylation of AKT. Moreover, bufotalin improved TMZ sensitivity of GBM cells in vitro and in vivo. In conclusion, bufotalin enhances apoptosis and TMZ chemosensitivity of glioblastoma cells by promoting mitochondrial dysfunction via AKT signaling pathway.

15 December 2022 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
HWHuiping Wang
Huiping Wang
JWJin Wang
Jin Wang
CGChunsong Geng
Chunsong Geng
CWCong Wang
Cong Wang
RGRongrong Gu
Rongrong Gu
ZZZhansheng Zhu
Zhansheng Zhu